President Trump said this week that Hyperliquid, a crypto-native exchange built around perpetual futures, could be brought into compliance with US regulations. That single comment reopened a debate the industry has spent a year trying to settle. Perpetual futures, or perps, let a trader take 10x or 50x leverage on almost anything, with no expiration date, and the product is spreading from crypto into commodities, indexes, and single stocks.
CNBC’s Oliver Renick framed the scale on August 21. “Global perpetuals trading is pacing around 150 billion of notional per day. And that’s down from last year because crypto did so poorly. But the market is booming because perpetuals are shifting to commodities indexes like the S&P 500.”
The US-listed company sitting closest to this fight is CME Group (NASDAQ:CME | CME Price Prediction), the world’s largest derivatives exchange, with a market capitalization of roughly $98.9 billion. CEO Terry Duffy spent the summer arguing that perps are speculative instruments rather than hedging tools, while CME has told investors it stands ready to list them if clients demand it.
That gap between stated principle and commercial reality is the story worth understanding, because the classification decision now sitting at the CFTC will reshape what leverage looks like for ordinary US traders.
What a Perpetual Future Actually Is
A dated futures contract has an expiration. You know the settlement date, the size, and the price at which you will be marked out if you hold to the end. That certainty lets a corporate hedger match a contract to a real exposure.
A perpetual future removes the expiration and replaces it with a funding-rate mechanism. Longs and shorts pay each other periodically to keep the contract’s price tethered to spot, which Duffy described as “highly engineered instruments that rely on frequent funding rate adjustments that revert the position back to the spot price.”
The second feature is automated liquidation. When a leveraged position drifts against the trader, the exchange closes it algorithmically to protect the clearing pool, and at 50x leverage the margin for error is extremely thin.
Duffy’s plainest description was that “while this product may be dubbed futures, they function more like leveraged spot products.” For a retail trader, that distinction matters, because the appeal marketed as “no expiration” hides a running funding cost and a liquidation trigger.
Duffy’s Warning and CME’s Own Contradiction
On the July 22, 2026 earnings call, Duffy said 94% of volume in the first half of 2026 came from institutional customers, and those customers told him perps do not serve their risk-management needs.
He also acknowledged the commercial reality. CME has “the full technical and operational capabilities to launch perpetual futures” and has drafted contract specifications. Renick captured the tension: “These products treat ten x, 50x leverage like a volume toggle, and critics like CME’s Terry Duffy argue that confines perps to speculative instruments, not hedging tools.”
CME is launching single-stock futures financially settled to the closing print, starting with the 22 biggest names, and Julie Winkler said retail brokers view it as “the single biggest retail growth catalyst of the year.”
The stock has responded to the strategic pivot. CME is up 10.33% over the past month and closed Friday at $274.98, with the sell-side target sitting near $283.07.
Swaps or Futures Is the Whole Ballgame
Renick’s most important line was the quiet one. “The difference between swaps and futures is huge, and there’s a bit of irony here that despite the growth of this sector, that we’re still debating on what to call it. Because if it is indeed swaps, that’s going to change the collateral requirements by exchanges in a very big way.”
Collateral is where consumer protection actually lives. Duffy argued that under Dodd-Frank, any product where two parties exchange funding payments “is a swap contract”, and swaps “need to be margined for five days” rather than the one-day standard for cleared futures.
A five-day margin requirement effectively prices 50x retail leverage out of existence, which is why the classification fight is the whole ballgame. Duffy warned that an equity perp structured like today’s crypto perps could create “a systemic issue for the marketplace” if cascading auto-liquidations hit both sides simultaneously. Retail traders drawn to that kind of leverage can still play, but the sizing and exit rules matter more than the entry, which is the whole subject of our free speculation playbook.
The realistic outcome is that the CFTC eventually classifies most perp designs as swaps for margining purposes, which would push US-compliant versions toward lower leverage caps and drive listing rights to established venues like CME under its index licenses. Watch the CFTC docket, watch whether a major US exchange files a perpetual contract under 40.2 self-certification, and read CME’s Q2 8-K for whether Duffy’s tone shifts from warning to filing.
Contact [email protected] for any questions or corrections.
Top Gaining Stocks
Top Losing Stocks